ENDRA Life Sciences Inc. - Common Stock (NQ:NDRA)

5.900 -0.060 (-1.01%)

Delayed Quote Updated: 1:09 PM EDT, Oct 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ENDRA Life Sciences Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Top Penny Stocks Today: Why ATER, BFRI, NDRA, MDVL and LYRA Stocks Are Soaring Friday ↗

April 08, 2022

We're diving into the top penny stocks for today in our market update for Friday with all the latest news that's moving shares!

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

April 08, 2022

Good morning, trader! Get ready for another busy day of trading with our breakdown of the biggest pre-market stock movers for Friday!

Via InvestorPlace

16 Stocks Moving in Friday's Pre-Market Session ↗

April 08, 2022

Gainers Biofrontera Inc. (NASDAQ: BFRI) rose 34.5% to $5.44 in pre-market trading. ENDRA Life Sciences Inc. (NASDAQ: NDRA) rose 31.9% to $0.5891 in pre-market trading after...

Via Benzinga

ENDRA Life Sciences Achieves Key Quality Management System Certification

March 31, 2022

From ENDRA Life Sciences Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Monday ↗

February 14, 2022

During Monday's session, 291 companies made new 52-week lows. Also check out this: Insiders Buying These 4 Penny Stocks Noteable 52-Week Lows And Highs: SAP (...

Via Benzinga

ENDRA Life Sciences: Q4 Earnings Insights ↗

March 30, 2022

ENDRA Life Sciences (NASDAQ:NDRA) reported its Q4 earnings results on Wednesday, March 30, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings ENDRA Life Sciences...

Via Benzinga

ENDRA Life Sciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

March 30, 2022

From ENDRA Life Sciences Inc.

Via Business Wire

ENDRA Life Sciences Strengthens TAEUS® System Global Intellectual Property Protection with Issuance of 10th and 11th Chinese Patents

March 30, 2022

From ENDRA Life Sciences Inc.

Via Business Wire

Earnings Preview: ENDRA Life Sciences ↗

March 29, 2022

ENDRA Life Sciences (NASDAQ:NDRA) is set to give its latest quarterly earnings report on Wednesday, 2022-03-30. Here's what investors need to know before the announcement. Analysts estimate that ENDRA...

Via Benzinga

Earnings Scheduled For March 30, 2022 ↗

March 30, 2022

Companies Reporting Before The Bell • Orgenesis (NASDAQ:ORGS) is likely to report earnings for its fourth quarter. • RumbleON (NASDAQ:RMBL) is estimated to report earnings for its Fiscal Year 2021.

Via Benzinga

ENDRA Life Sciences to Report Fourth Quarter 2021 Financial Results on March 30, 2022

March 22, 2022

From ENDRA Life Sciences Inc.

Via Business Wire

The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More ↗

March 27, 2022

Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

March 11, 2022

Gainers CVRx (NASDAQ:CVRX) shares rose 11.6% to $7.2 during Friday's after-market session. The market value of their outstanding shares is at $156.2 million.

Via Benzinga

The Stock Day Podcast Hosted ENDRA Life Sciences Inc. to Discuss the Potential of its Thermo Acoustic Enhanced UltraSound (TAEUS(R))

February 15, 2022

Phoenix, Arizona--(Newsfile Corp. - February 15, 2022) - The Stock Day Podcast welcomed ENDRA Life Sciences Inc. (NASDAQ: NDRA) ("the...

Via Newsfile

25 Stocks Moving in Monday's Pre-Market Session ↗

February 14, 2022

Gainers Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 52.8% to $0.65 in pre-market trading after declining 6% on Friday. TC BioPharm (Holdings) plc (NASDAQ: TCBP)...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

February 11, 2022

Gainers Dermata Therapeutics (NASDAQ:DRMA) shares moved upwards by 26.6% to $1.35 during Friday's regular session. As of 12:30 EST, Dermata Therapeutics's stock is...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 11, 2022

Gainers Dermata Therapeutics (NASDAQ:DRMA) stock rose 29.0% to $1.38 during Friday's pre-market session. The company's market cap stands at $11.4 million. Innoviva...

Via Benzinga

ENDRA Life Sciences Strengthens TAEUS® System Global Intellectual Property Portfolio with Issuance of 6th and 7th European Patents

February 11, 2022

From ENDRA Life Sciences Inc.

Via Business Wire

62 Biggest Movers From Yesterday ↗

February 11, 2022

Gainers American Rebel Holdings, Inc. (NASDAQ: AREB) shares jumped 42.8% to close at $3.07 on Thursday following the company's recent uplisting to the Nasdaq....

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

February 10, 2022

On Thursday, 89 companies hit new 52-week lows. Noteable 52-Week Lows: The company with the largest market cap to set a new 52-week low was Seagen (NASDAQ:SGEN)....

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

February 10, 2022

Gainers Dermata Therapeutics (NASDAQ:DRMA) shares moved upwards by 26.1% to $1.35 during Thursday's regular session. The current volume of 17.5 million shares is 7266....

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

February 10, 2022

Gainers Dermata Therapeutics (NASDAQ:DRMA) stock moved upwards by 27.1% to $1.36 during Thursday's pre-market session. The company's market cap stands at $11.3...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

February 10, 2022

Good morning, trader! Rub that sleep out our your eyes because we're going over the biggest pre-market stock movers for Thursday!

Via InvestorPlace

ENDRA Life Voluntarily Withdraws 510(k) Application For Liver Fat Measuring System ↗

February 10, 2022

ENDRA Life Sciences Inc (NASDAQ: NDRA) plans to voluntarily withdraw its 510(k) application, currently under FDA review for its TAEUS System. Instead, the Company will...

Via Benzinga

ENDRA Life Sciences Provides Update on U.S. Regulatory Strategy for its TAEUS® System

February 09, 2022

From ENDRA Life Sciences Inc.

Via Business Wire

ENDRA Life Sciences Expands into China with Shanghai General Hospital Partnership

January 24, 2022

From ENDRA Life Sciences Inc.

Via Business Wire

ENDRA Life Sciences to Present at the H.C. Wainwright BioConnect Virtual Conference

January 05, 2022

From ENDRA Life Sciences Inc.

Via Business Wire

ENDRA Life Sciences Announces New Clinical Study Partnership with King’s College Hospital, London

December 13, 2021

From ENDRA Life Sciences Inc.

Via Business Wire

ENDRA Life Sciences Expands Pharmaceutical Partnerships with VGI Health Technology to Provide TAEUS for Patient Screening and Biomarker Measurement for Phase 2 Study

November 29, 2021

From ENDRA Life Sciences Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

November 17, 2021

Gainers Rani Therapeutics Hldgs (NASDAQ:RA...

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.